Characterization of the Duffy-Binding-Like Domain of Plasmodium falciparum Blood-Stage Antigen 332

Author:

Nilsson Sandra1,Moll Kirsten1,Angeletti Davide1,Albrecht Letusa1,Kursula Inari23,Jiang Ning4,Sun Xiaodong5,Berzins Klavs6,Wahlgren Mats1,Chen Qijun17

Affiliation:

1. Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden

2. Department of Medical Biochemistry and Biophysics, Karolinska Institutet, 171 77 Stockholm, Sweden

3. Centre for Structural Systems Biology, Helmholtz Centre for Infection Research and Deutsches Elektronen-Synchrotron, University of Hamburg, 22607 Hamburg, Germany

4. Key Laboratory of Zoonosis, Ministry of Education, Jilin University, Changchun 130062, China

5. Institute of Parasitic Disease Control, Puer City, Yunnan Province, China

6. Department of Immunology, Wenner-Gren Institute, Stockholm University, 106 91 Stockholm, Sweden

7. Laboratory of Parasitology, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Beijing 100730, China

Abstract

Studies on Pf332, a major Plasmodium falciparum blood-stage antigen, have largely been hampered by the cross-reactive nature of antibodies generated against the molecule due to its high content of repeats, which are present in other malaria antigens. We previously reported the identification of a conserved domain in Pf332 with a high degree of similarity to the Duffy-binding-like (DBL) domains of the erythrocyte-binding-like (EBL) family. We here describe that antibodies towards Pf332-DBL are induced after repeated exposure to P. falciparum and that they are acquired early in life in areas of intense malaria transmission. Furthermore, a homology model of Pf332-DBL was found to be similar to the structure of the EBL-DBLs. Despite their similarities, antibodies towards Pf332-DBL did not display any cross-reactivity with EBL-proteins as demonstrated by immunofluorescence microscopy, Western blotting, and peptide microarray. Thus the DBL domain is an attractive region to use in further studies on the giant Pf332 molecule.

Funder

National Basic Research Program of China

Publisher

Hindawi Limited

Subject

Infectious Diseases,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3